Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Thorax
Journal
Overview
Identity
Overview
Publication Venue For
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
. 77:589-595.
2022
Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: Secondary analysis of SAILS-ALTOS trial
. 77:22-30.
2022
Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
2021
Respiratory exacerbations are associated with muscle loss in current and former smokers
. 76:554-560.
2021
Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers
. 76:335-342.
2021
Structural airway imaging metrics are differentially associated with persistent chronic bronchitis
. 76:343-349.
2021
Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits
. 75:520-527.
2020
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years
. 73:414-421.
2018
Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults.
. 72:1113-1120.
2017
Are physical measures related to patient-centred outcomes in ARDS survivors?
. 72:884-892.
2017
Mastering the design for rehabilitation strategies in ICU survivors
. 72:594-595.
2017
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
. 72:318-326.
2017
Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice
. 72:180-182.
2017
Biomechanical CT metrics are associated with patient outcomes in COPD
. 72:409-414.
2017
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis
. 71:1082-1090.
2016
One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: Prospective follow-up of SAILS randomised trial
. 71:401-410.
2016
β-Blockers are associated with a reduction in COPD exacerbations
. 71:8-14.
2016
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia
. 70:41-47.
2015
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' response
. 69:1147-1148.
2014
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction
. 69:409-414.
2014
Progress in cystic fibrosis and the CF Therapeutics Development Network
. 67:882-890.
2012
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease
. 67:399-406.
2012
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
. 67:12-18.
2012
Genome-wide association study of smoking behaviours in patients with COPD
. 66:894-902.
2011
Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension
. 66:1097-1098.
2011
PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice
. 66:788-796.
2011
Pneumocystis jirovecii in pleural infection: A nucleic acid amplification study
. 66:450-451.
2011
Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: Role of Hsp90 and Hsp70
. 65:346-353.
2010
Gastro-oesophageal reflux and aspiration in patients with advanced lung disease
. 64:167-173.
2009
Authors' response
. 63:1026.
2008
Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
. 63:301-305.
2008
Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients
. 63:154-159.
2008
Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade
. 63:147-153.
2008
Authors' response
. 63:1027.
2008
Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis
. 63:935-936.
2008
Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy
. 62:964-968.
2007
Author's reply [6]
. 62:924.
2007
Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy
. 61:716-721.
2006
A&E department: A missed opportunity for diagnosis of TB? [4]
. 61:364-365.
2006
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection
. 61:791-794.
2006
Genotypic variation in Pneumocystis jirovecii isolates in Britain
. 60:679-682.
2005
Pneumocystis jirovecii infection
. 59:731-733.
2004
Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii (5) [multiple letters]
. 59:83-84.
2004
Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: A prospective study
. 58:594-597.
2003
Changes in nitric oxide synthase activity in the porcine lung after birth
. 53.
1998
Nebulisers for patients with HIV infection and AIDS
. 52.
1997
Alveolar lymphocytes and macrophages are an important source of HIV-1 in patients with AIDS
. 51.
1996
Genotypic variants of HIV-1 from peripheral blood and lung of AIDS patients
. 51.
1996
Authors' Reply
. 50:1227.
1995
Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200))
. 50:1228.
1995
Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200))
. 50:1228.
1995
Interstitial pneumonitis in patients infected with the human immunodeficiency virus
. 50:1141-1146.
1995
New developments in the pulmonary diseases affecting HIV infected individuals
. 50:294-302.
1995
Pneumocystis carinii pneumonia
. 50:191-200.
1995
Role of the human immunodeficiency virus within the lung
. 50:567-576.
1995
Community acquired lobar pneumonia in patients with HIV infection and AIDS
. 49:367-368.
1994
Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1
. 48:204-207.
1993
Histologically atypical Pneumocystis carinii pneumonia
. 48:996-1001.
1993
Bronchopulmonary Kaposi's sarcoma in patients with AIDS
. 47:721-725.
1992
Pneumocystis carinii pneumonia
. 47:305-314.
1992
Arterial desaturation in HIV positive patients undergoing sputum induction
. 46:449-451.
1991
AIDS and the lung: 5 - Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus
. 45:62-65.
1990
Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage (I: Reply)
. 45:302.
1990
Granulomatous Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome
. 45:769-771.
1990
Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia
. 45:140-146.
1990
Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage
. 44:554-558.
1989
Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
. 44:559-564.
1989
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
. 44:565-569.
1989
Empyema after internal jugular catheterisation in rheumatoid arthritis
. 36:958-959.
1981
Identity
International Standard Serial Number (issn)
0040-6376
Electronic International Standard Serial Number (eissn)
1468-3296